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The distribution of malaria infections is heterogeneous in space and time, especially in low 
transmission settings. Understanding this clustering may allow identification and targeting of pockets 
of transmission. In Adama district, Ethiopia, Plasmodium falciparum and P. vivax malaria patients 
and controls were examined, together with household members and immediate neighbors. Rapid 
diagnostic test and quantitative PCR (qPCR) were used for the detection of infections that were 
genetically characterized by a panel of microsatellite loci for P. falciparum (26) and P. vivax (11), 
respectively. Individuals living in households of clinical P. falciparum patients were more likely to have 
qPCR detected P. falciparum infections (22.0%, 9/41) compared to individuals in control households 
(8.7%, 37/426; odds ratio, 2.9; 95% confidence interval, 1.3–6.4; P = .007). Genetically related P. 
falciparum, but not P. vivax infections showed strong clustering within households. Genotyping 
revealed a marked temporal cluster of P. falciparum infections, almost exclusively comprised of clinical 
cases. These findings uncover previously unappreciated transmission dynamics and support a rational 
approach to reactive case detection strategies for P. falciparum in Ethiopia.
Recent success in malaria control in endemic countries has re-ignited elimination  efforts1. Transition from 
control to elimination requires improved understanding of transmission patterns within  communities2 to better 
target the remaining infections that sustain or seed transmission. In low endemic settings, malaria infections are 
often characterized by low parasite density, commonly below the detection limit of rapid diagnostic tests (RDT) 
and  microscopy3,4. These low-density infections are typically asymptomatic and may contribute substantially to 
onwards transmission to  mosquitoes5.
As malaria transmission intensity declines, the distribution of malaria infections becomes increasingly het-
erogeneous, and infections may cluster within villages or  households6–8. If this clustering reflects pockets of active 
transmission, finding and targeting these clustered infections may accelerate targeted elimination  efforts9. Based 
on this assumption, individuals living in close proximity to passively detected cases are screened and treated in 
reactive case detection (RCD) strategies in low transmission  settings8. The optimal and logistically feasible popu-
lation that needs to be targeted in RCD remains  unclear10,11. Several studies have attempted to determine whether 
geographical clusters of infections show evidence of increased genetic relatedness and thus truly reflect related 
transmission  events12–18. Few studies have coupled household-level case clustering studies with information on 
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the genetic relatedness of infections. Such studies can provide a better understanding of fine-scale transmission 
patterns and estimate the contribution to transmission of infections that are not detected by routine interventions.
In this study, the prevalence and distribution of asymptomatic P. falciparum and P. vivax infections sur-
rounding passively detected RDT-confirmed clinical malaria patients was assessed using RDT and quantitative 
PCR (qPCR) in Batu Degaga, Ethiopia. Spatial and temporal relatedness and clustering of infections within and 
between households of passively detected malaria infections and controls were investigated by genotyping 26 
and 11 microsatellite loci for P. falciparum and P. vivax, respectively, which had been shown previously to be 
useful to describe population  structure12,19–25.
Results
Prevalence and clustering of malaria infections. Family members and neighbors of 18 passively 
detected index cases with RDT confirmed P. falciparum (n = 10), P. vivax (n = 6) or mixed species infections 
(n = 2) and 18 controls without malaria infections participated in this study. In total, 499 individuals from 128 
households around index cases and 454 individuals from 108 households around controls were successfully 
sampled (Fig. 1). The median number of individuals examined was 28 around index cases (interquartile range 
[IQR], 24–31) and 26 around controls (IQR, 22–30), with a median of 4 individuals (IQR, 3–5) examined per 
household. Reported history of malaria in the last 3 weeks was substantially higher among individuals in index 
HHs (38.8%, 31/88; P < 0.001) compared with their neighbors (22.2%, 92/414) and those from and around con-
trol HHs (4.3%, 19/447). In the screened population surrounding index cases and controls (excluding the index 
cases), prevalence of infection was 7.9% (72/913) by RDT and 21.6% by qPCR (189/877). At least one infected 
individual was found in 28% (66/236) and 48% (114/236; P < 0.001) of households by RDT and qPCR, respec-
tively. P. falciparum infections detected in households of neighbors of index cases had higher parasite density 
(median parasite density by qPCR, 203 copies/μL; IQR, 33–576) than infections detected in households of neigh-
bors of controls (median, 75 copies/μL; IQR, 17–209; P = 0.037); whilst such difference was not detected in P. 
vivax infections (P = 0.27). Fewer P. falciparum infections were detected by qPCR in households of controls 
(8.6%, 37/432) compared to index case households (20.3%, 12/59; OR, 2.7; 95% CI 1.3–5.6; P = 0.01) after exclud-
ing index cases. There was no evidence for differences in parasite prevalence by PCR between households of 
control and neighbors of index cases (10.4%, 41/395; OR 1.2; 95% CI 0.8–2.0; P = 0.37; Fig. 2). For P. vivax infec-
tions, no such differences were detected in qPCR parasite prevalence in relation to proximity to the household 
of the index case (P = 0.53; Fig. 2). 
Figure 1.  Flow chart of samples collected and genotyped. Indicated in the figure is the number of index cases 
and controls and individuals screened around them. Parasite identification results by RDT and qPCR are also 
indicated. Of all samples with complete metadata that were tested using both RDT and qPCR (n = 889) only 5 P. 
falciparum and 1 mixed species infection were qPCR negative whilst being positive. All RDT positive samples 
were genotyped except these six samples. Parasite densities (18S copies/µL) are indicated for each species in 
(median, interquartile range [IQR]). Indicated at the bottom are number of samples that were genotyped for 
each species. DBS, dried blood spot; RDT, rapid diagnostic test; Pf, P. falciparum; Pv, P. vivax; qPCR, quantitative 
polymerase chain reaction; IQR, interquartile range.
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Genetic complexity and diversity of P. falciparum and P. vivax infections. A total of 92 P. fal-
ciparum infections and 99 P. vivax infections were successfully genotyped. The number of genetically distinct 
parasite clones (i.e. multiplicity of infections, MOI) and population level genetic diversity were compared for 
infections around index and control cases for each species. In P. falciparum infections, the mean MOI was 1.5 
(range: 1–3) and infections detected in and around households of index cases had higher MOI compared to 
those detected in and around control households (mean MOI: 1.6 vs. 1.4; P = 0.04; Fig. 3A). When stratified by 
index and controls, infections detected around index cases showed moderately higher genetic diversity com-
pared to those detected around controls in P. falciparum (Mean  HE: 0.56 vs. 0.49; P = 0.03; Fig. 3B).
In contrast to the sympatric P. falciparum populations, within-host diversity was consistently higher in P. 
vivax, the mean MOI was higher in P. vivax (mean MOI = 2.2; range: 1–6), with no difference between index and 
control cases (mean MOI 2.2 vs. 2.3; P = 0.35; Fig. 3C). The overall genetic diversity of P. vivax infections was high 
(Mean  HE ± SE: 0.82 ± 0.03). Similar to P. falciparum, infections detected around index cases showed moderately 
higher genetic diversity compared to those detected around controls (Mean  HE: 0.84 vs. 0.79; P = 0.08; Fig. 3D).
Spatial and temporal relatedness of P. falciparum and P. vivax infections. Pairwise genetic relat-
edness in 70 P. falciparum samples from 57 households (with allele calls from at least 15 loci) and 91 P. vivax 
samples from 79 households (with allele calls from at least 6 loci) were compared using the IBS metric. These 
data were used to determine how genetic relatedness of infections varied in space and time. P. falciparum infec-
tions sampled from the same household were more strongly related than infections from different households 
(median genetic relatedness: 0.81 vs. 0.37, P < 0.001; Fig. 4A). The degree of relatedness did not differ depending 
on household distance. P. falciparum infections that were genetically related (IBS > 0.5) and sampled from differ-
ent households (Fig. 4B), were sampled within a shorter time frame compared to unrelated infections (median 
number of days: 17 vs. 25, P < 0.001; Fig. 4C), suggesting temporal clustering of genetically related P. falciparum 
infections. In contrast, overall pairwise genetic relatedness between P. vivax infections was low, with no spatial 
(Fig. 4D,E) or temporal clustering (Fig. 4F).
Fine‑scale population structure of P. falciparum but not P. vivax infections. Analysis of domi-
nant alleles at each locus using MavericK identified three sub-populations (K = 3), with the highest model evi-
dence for both P. falciparum and P. vivax. Most parasites had their origin clearly assigned to a single cluster; 
few of them were admixed as shown by bars partitioned into K colored segments (Fig. 5). P. falciparum infec-
tions detected around index cases vs. controls were comprised of different populations (Fig. 5A), with infections 
belonging to group-3 almost exclusively detected in and around index cases households (23% vs. 4%, P = 0.010) 
and group-1 overrepresented in controls (72% vs. 42%, P = 0.003). Infections assigned to group-3 were identified 
in five independent RCD investigations and included one individual in the control group whose infection was 
genetically related to one of the index cases (IBS = 0.7). Analyses of the elapsed time between samples in each 
group showed that infections assigned to group-3 were clustered temporally (median number of days = 16, IQR: 
0–30) compared to group-1 (23, IQR: 12–42; P = 0.007) and group-2 (25, IQR: 7–41; P = 0.004). These observa-
tions support the hypothesis that infections identified through investigation around index cases are linked pos-
sibly due to recent, local spread of group-3 haplotypes during the study period. No P. vivax genetic groups were 
overrepresented either to the control or index cases (Fig. 5B).
Figure 2.  Comparison of the odds of detecting infections around households. The forest plot shows the 
odds ratio and 95% confidence interval for detecting asymptomatic malaria infections by 18S based qPCR 
in households of index cases (Index HH) and neighbors of index cases compared to control households 
(community control) for P. falciparum and P. vivax infections separately after excluding the index cases. 
Indicated on the X-axis the  Log10 transformed odds ratio and on Y-axis are the different comparison groups. The 
prevalence of RDT and qPCR detectable asymptomatic infections for each household category and species are 
also indicted for each group to the left of the figure.
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Discussion
In the current study, we examined spatial clustering of Plasmodium infections in a low endemic area in Ethiopia 
with a focus on asymptomatic infections in the vicinity of passively detected clinical index cases. Asymptomatic 
P. falciparum infections were clustered in index case households whilst there was no such evidence for clustering 
of P. vivax infections. P. vivax infections were more genetically complex and diverse than P. falciparum infec-
tions, with no detectable spatial or temporal clustering. We identified fine-scale focal transmission and a genetic 
cluster around index cases that may represent a clonal P. falciparum expansion, highlighting the added value of 
genotyping to understand the contrasting transmission epidemiology of the two Plasmodium species.
Spatial and temporal heterogeneity in the occurrence of infections is widely acknowledged in  malaria26,27 and 
other infectious  diseases28–30. Several countries have adopted RCD approaches that take advantage of infection 
clustering and assume that transmission chains, or at least transmission sources, can be interrupted by target-
ing infected household members. In some settings where symptomatic and asymptomatic malaria cases do not 
overlap spatially, clusters of infections can be missed by  RCD31. This highlights the need for detailed studies on 
Plasmodium transmission patterns in settings aiming for  elimination32. In the current study, we moved beyond 
spatial patterns in infection prevalence and examined small-scale transmission patterns by genotyping micros-
atellite markers. The overall genetic diversity (i.e. the mean expected heterozygosity) in P. falciparum infections 
Figure 3.  Genetic complexity and diversity of P. falciparum and P. vivax infections around index cases and 
controls. Distributions of multiplicity of infection (A and C) and the expected heterozygosity (B and D) of 
markers from samples collected in and neighboring households of index cases and controls are indicated for 
P. falciparum (A and B) and P. vivax (C and D). In (B and D), each dot represents one microsatellite marker. 
Boxplots indicate the medians and interquartile ranges of the heterozygosity of 25 loci for P. falciparum and 11 
loci for P. vivax. The P. falciparum AS1 locus was excluded from the analyses due to the lack of diversity in this 
population. The whiskers indicate the highest and lowest values.
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was lower (Mean  HE ± SE: 0.47 ± 0.03) than previously observed in other low transmission areas of Eswatini, 
Zambia, and Namibia (Mean  HE: 0.71–0.79)12,22,33 suggesting infrequent recombination and smaller parasite 
population size in the study site.
We observed a clear overlap of symptomatic and asymptomatic P. falciparum infections; the odds of 
detecting an infection within the household of clinical patients was significantly higher than in neighboring 
households8,18, 34,35. MOI and genetic diversity of infections were higher around passively detected P. falciparum 
compared to controls, indicative of higher transmission. We observed that the very strong household-level clus-
tering for P. falciparum was matched with strong genetic relatedness of infections within a household. Density 
of asymptomatic P. falciparum infections surrounding clinical cases was higher than in infections detected in 
control households. This might indicate that the former infections were acquired more recently compared to 
older, very low density infections detected in controls. All of these findings corroborate that RCD is useful to 
detect clusters of recently acquired P. falciparum infections. Results from control households, however, show 
that a substantial number of infections is not linked to index cases. As found in other  studies36,37, RCD alone is 
thus unlikely to achieve elimination.
We detected a genetic cluster of P. falciparum infections, present in multiple households, that was overrep-
resented in and around index cases. These findings suggest a possible population expansion of a single parasite 
genotype. We can hypothesize that possible expansion, occurring against the background of wide-spread asymp-
tomatic infections, could indicate introduction of a clone from another site. Its association with clinical cases 
suggests that some infections disproportionally give rise to  symptoms18.
As in other sites where P. falciparum and P. vivax are co-endemic, P. vivax was more diverse, showed high 
MOI, and exhibited lower levels of population  structure38–41. P. vivax diversity was similar to previous studies 
from Madagascar (Mean  HE: 0.80), PNG highlands (Mean  HE: 0.82) and lowlands (Mean  HE: 0.80) and higher 
than South Korea (Mean  HE: 0.56)42. There was no significant difference in the odds to detect a asymptomatic 
P. vivax infection in the household or neighbors of an index case compared to a control household. There was 
no difference in the MOI and heterogeneity of infections around passively detected P. vivax infections and con-
trols. No spatial clustering was observed for P. vivax. The loss of relatedness and household level clustering may 
reflect differences in the biology of these two Plasmodium species where the majority of clinical P. vivax cases 


























































































































Figure 4.  Spatial and temporal genetic relatedness of P. falciparum and P. vivax infections. Pairwise genetic 
relatedness is shown for sample pairs collected within and between households for P. falciparum (A) and P. vivax 
(D). The proportion of comparisons in each category that are related (above the 0.5 genetic relatedness threshold 
demarcated by the red dashed line) is shown at the top. Pairwise genetic relatedness is shown for sample pairs 
by physical distance bin for P. falciparum (B) and P. vivax (E). Box plots indicating the distributions of elapsed 
days for genetically related (IBS > 0.5) and unrelated infections are shown for P. falciparum (C) and P. vivax (F). 
Boxplots indicate the median and interquartile ranges, and the whiskers indicate the highest and lowest values.
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mosquito  bites43,44. This would contribute to considerable variation in the time between the original inoculation 
by mosquito bite and parasite detection in the bloodstream, and thus diffuse any genomic signal. In summary, 
RCD is not more effective than random screening to identify asymptomatic P. vivax infections in the study site.
Our findings highlight the value of genotyping approaches to infer spatial and temporal clustering of P. falci-
parum infections. Whilst infections are prevalent outside households of index cases, and thus may be missed by 
RCD approaches, a disproportionate number of infections may be targeted by  RCD45. Our finding of a possible 
population expansion of a single parasite genotype arising from a clone that was frequently detected in clinical 
cases further supports RCD approaches that may interrupt clinically relevant transmission chains. The lack of 
spatial (genetic) clustering in P. vivax may be attributable to the limitations of the methods used in this study, 
in addition to its unique biology discussed above, calling for more robust approaches. The biology of P. vivax; 
existence of  hypnozoites43,46,47, generation of gametocytes at the very early  stage48, lower parasite  densities49,50, 
and higher vectoral  capacity51–53, makes it a harder species to control and one that may require a different strat-
egy to that of P. falciparum54,55. Future studies may benefit from more sample size and including genotyping of 
mosquitoes paired with the human sampling in study  households56. In summary, for P. vivax RCD may not be 
more efficient than untargeted screening to identify asymptomatic infections in the study site. Control strate-
gies against P. vivax need to target hypnozoites using radical cure, as the majority of infections detected are 
attributable to relapsing episodes rather than active  infections57. Justified by the very low prevalence of glucose-
6-phosphate dehydrogenase  deficiency58–64. Ethiopia is currently implementing a 14-day dose primaquine for 
radical cure in P. vivax65–67.
Methods
Study site, population and ethics statement. This study was conducted between October and 
December 2016 in Batu Degaga within Adama district, Ethiopia. Adama district is located at an altitude range 
of 1400–2300 m above sea level, and has an estimated population of 183,502 within 38,230 households (District 
Health Office Report). P. falciparum and P. vivax are co-endemic in the  district5,68 with 60% of the infections 
attributed to P. vivax5. The area is characterized by unstable seasonal transmission that peaks following the two 
rainy seasons: September to November (major) and April to May (minor). Two health posts, the lowest level 
governmental heath facilities, serve the study area. Only one of the two health posts (the southern health post, 
Fig. 6) was providing service during the entire study period. The northern health post was opened only for 3 days 
during the study period.
The study was approved by the ethics review boards of the Department of Medical Biochemistry at Addis 
Ababa University (DRERC 19/16), Armauer Hansen Research Institute (PO52/14), the National Research Eth-
ics Review Committee (310/109/2016), and the London School of Hygiene and Tropical Medicine (10628). 
Written informed consent was obtained from all participants and/or parents/guardians. All experiments were 
performed in accordance with permission obtained from participants on the consent forms, following relevant 
guidelines and regulations. If participant was found RDT positive while being febrile during household level 
sampling, he/she was referred to the nearest health post to be treated with current first-line antimalarial drugs 
according to the Ethiopian national malaria treatment guidelines, artemether–lumefantrine for P. falciparum 
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Figure 5.  Fine-scale population structure and focal transmission of genetically related infections. Population 
cluster analysis of P. falciparum (A) and P. vivax (B) microsatellite haplotypes from dominant alleles for cases 
detected around index cases and controls. Individual ancestry coefficients and optimum K value (K = 3) are 
shown as inferred by  MavericK70. Each vertical bar represents an individual haplotype, and its membership 
to the three population groups is defined by the different colors. Black borders separate individuals detected 
around controls and index cases.
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Sample collection and laboratory procedures. Patients with (history of) fever that presented to the 
two health posts and tested positive by RDT (First Response Malaria Ag. pLDH/HRP2 Combo Card Test; Pre-
mier Medical Corporation Limited, Valsad, Gujarat, India) were classified as index cases. Patients that were sus-
pected of malaria but tested RDT negative on the same day were included as controls. Individuals who attended 
the health post for vaccination, trauma, pregnancy test, antenatal care, and family planning were not considered. 
Index cases were independent of one another (i.e. they wouldn’t be found in the same cluster of households 
assessed for another index case). A total of 147 patients attended the clinic during the study period of whom 52 
presented with main complaint of fever. Fever was confirmed in 44 of them of whom 24 were RDT positive for 
malaria. Patients who were referred to the nearby health center for better treatment (n = 4), were not residents 
of the study area (n = 2), or did not have completed information (n = 2) were excluded from the study. Controls 
were recruited among patients that presented to the same health post where the index case was recruited.
During the study period, 0–6 patients attended the clinic in a day and the health extension workers were avail-
able for 2–3 days a week from 9:00–12:00 a.m. The northern health post was opened occasionally and the same 
health extension workers were responsible and two index cases and two controls were recruited. Household mem-
bers and members of the six nearest neighboring households of index cases and controls were tested for malaria 
by RDT within 2 days after the index or control cases were  identified8 and had their household geo-located with 
a handheld GPS receiver (GPSMAP 62 s; Garmin International). Neighboring households were selected based 
on proximity to the respective index case or control household upon obtaining permission from the head of the 
house. Socio-demographic and epidemiological data were collected, together with finger prick blood samples 
to diagnose malaria using RDT and to prepare dried blood spots (DBS) on 3MM Whatman papers (Whatman, 
Maidstone, UK) from all study participants including index cases, controls, neighbors and household members.
DNA was extracted from a 6 mm diameter punch, using MagNa Pure LC 2.0 Instrument and Total Nucleic 
Acid Kit—High Performance (Roche Life Sciences) with prior treatment using Buffer ATL (QIAGEN) and Pro-
teinase K (QIAGEN)5. Parasites were quantified using species-specific qPCR that targeted the 18S small subunit 
rRNA  gene69. qPCR positive samples were genotyped using 26 microsatellite markers for P. falciparum and 11 
markers for P. vivax using previously established laboratory and data analyses  protocols12,19–23. Mixed species 
infections were genotyped with both P. falciparum and P. vivax markers. Genotyping was successful in 92/93 
P. falciparum and 99/123 P. vivax positive samples. For haplotype reconstruction in multiclonal infections, the 
predominant peak was included.
Figure 6.  Map of study area and distribution of study households. Shown in the right bottom corner is a map 
of Ethiopia with boundaries indicating administrative regions (asterisk indicating the study district, Adama, 
Oromia region). The location of index households (thick circles; P. falciparum, dark blue; P. vivax, blue; mixed 
species, light blue) and neighbors of index households (thin circles) surveyed during the study are indicated 
together with control households (thick triangles) and neighbor households of controls (think triangles). The 
two health posts are indicated in black and bold letter ‘H’. The entire study area was 0.031  km2. The QGIS 
software version 3.14.16 (QGIS developer team, Open Source Geospatial Foundation Project) was used to map 
study households (https ://issue s.qgis.org/proje cts/qgis/). Coordinates of study household were geo-located with 
a handheld GPS receiver (GPSMAP 62 s; Garmin International).
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Statistical analysis. GraphPad Prism version 5.03 for Windows (GraphPad Software, La Jolla California 
USA, http://www.graph pad.com); STATA 13 (StataCorp., TX, USA) and R (R Core Team, Vienna, Austria) 
were used for data analysis. The QGIS software version 3.14.16 (QGIS developer team, Open Source Geospatial 
Foundation Project) was used to map study households. Continuous variables were presented as median and 
interquartile range (IQR). Tests of association between two categorical variables were performed using the Chi 
squared test, and comparison of non-normally distributed continuous variables by Mann–Whitney U test. Odds 
ratios (OR) with 95% confidence intervals (95% CI) were calculated using Generalized Estimating Equations to 
determine the association between being parasite positive and living in households of index cases or surround-
ing houses. These estimates were adjusted for clustering of species-specific observations from the same house-
hold with robust standard errors and used community members not belonging to index cases or neighboring 
households as a reference.
Multiplicity of Infection (MOI) was defined as the highest number of alleles detected by at least two loci, 
reducing the impact of false positive allele calls from a single, outlier  locus12,22. Population-level genetic diversity 
was determined by the expected heterozygosity  (HE) of each locus.  HE was calculated for each locus using the 
formula HE = nn−1 [1−
∑
pi
2] , where n = the number of isolates analyzed and pi = the allele frequency of the ith 
allele in the population. Mean  HE was calculated by taking the average of  HE across all loci. To assess the genetic 
relatedness and clustering of P. falciparum and P. vivax infections, pairwise genetic relatedness was determined for 
each pair of samples using a modified identity by state (IBS)  metric22. Briefly, pairwise IBS was calculated based 
on the number of shared alleles between isolates, allowing estimation of genetic relatedness from monoclonal 
as well as polyclonal samples. Samples were considered related if the pairwise genetic relatedness was greater 
than or equal to 0.5 (i.e. at least 50% of microsatellite markers shared the same alleles). This threshold reflects 
the degree of relatedness of meiotic siblings, which are the result of sexual recombination of different clones in 
the mosquito. Population structure was assessed using the program  MavericK70, under the admixture model 
with 500 burn-in iterations, 5000 sampling iterations and 20 thermodynamic rungs.
Consent for publication. This work does not contain any individual person’s data in any form (including 
any individual details, images or videos).
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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